Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2016

View Archived Issues

miRagen Therapeutics and the ALS Association receive grant to develop ALS therapy

High endostatin levels may provide protective effect against cardiovascular events

Phase I study determines regimen for palbociclib with 5-fluorouracil in advanced solid tumors

Terumo launches HeartSheet in Japan

EpimAb Biotherapeutics announces agreement with Innovent Biologics

Protalix BioTherapeutics initiates global phase III study of PRX-102 in Fabry disease

GlaxoSmithKline discloses NAD-dependent SIRT1 activators

Medgenics collaborates with Kyowa Hakko Kirin on anti-LIGHT monoclonal antibody for pediatric IBD

Takeda Pharmaceutical and Roivant Sciences form Myovant Sciences

GeoVax begins HBV vaccine development program

Seres Therapeutics signs agreement with the Mayo Clinic

RealStar Zika virus test available in U.S.

Ocular Therapeutix's phase III trial of Dextenza does not meet primary endpoint

Adamis Pharmaceuticals receives FDA response on Epinephrine Injection

FDA approves Allergan's FDC Byvalson for hypertension

FDA requests further data to enable review of eteplirsen NDA

Scientists identify two novel mutations causing type I hyperlipoproteinemia

Vonosap and Vonopion packs launched in Japan for H. pylori eradication

TRX-518 is safe in patients with advanced solid tumors

Fusion peptide of HIV-1 as target for vaccine design

Targeting kynurenine pathway as promising therapeutic strategy for neurodegenerative disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...